Document Detail

Excellent lithium responders have normal cognitive functions and plasma BDNF levels.
MedLine Citation:
PMID:  20392298     Owner:  NLM     Status:  MEDLINE    
In bipolar patients, neuropsychological and biochemical disturbances persist into the remission period. Excellent lithium responders (ELRs) comprise around one third of lithium-treated patients and have total remission of recurrences on lithium monotherapy. The objective of the study was to assess the performance on neuropsychological tests and to measure brain-derived neurotrophic factor (BDNF) plasma levels in ELRs compared to patients where the effect of lithium was not optimal, and with matched healthy control subjects. The study was performed with 60 patients on prophylactic lithium treatment, 13 of whom were ELRs, and with 60 matched healthy controls. Neuropsychological tests from the CANTAB battery measuring spatial working memory and sustained attention were used. ELRs performed better on all neuropsychological tests, and had higher plasma BDNF levels than the remaining lithium patients but not different from those of healthy controls. ELRs may constitute a specific subgroup of bipolar patients in which long-term lithium administration can produce complete normality.
Janusz K Rybakowski; Aleksandra Suwalska
Related Documents :
52008 - Acute folate deficiency in surgical patients on aminoacid/ethanol intravenous nutrition.
3770278 - Recovery of reproductive function in patients with anorexia nervosa: a 10-year follow-u...
8256648 - Intoxication in manic patients following chaotic self-administration of lithium.
17986558 - Nutritional requirements and actual dietary intake of continuous ambulatory peritoneal ...
2391618 - The acuity card procedure: longitudinal assessments.
23937618 - Real time three-dimensional transesophageal echocardiography: a novel approach for the ...
Publication Detail:
Type:  Comparative Study; Journal Article     Date:  2010-04-15
Journal Detail:
Title:  The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)     Volume:  13     ISSN:  1469-5111     ISO Abbreviation:  Int. J. Neuropsychopharmacol.     Publication Date:  2010 Jun 
Date Detail:
Created Date:  2010-05-18     Completed Date:  2011-01-25     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9815893     Medline TA:  Int J Neuropsychopharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  617-22     Citation Subset:  IM    
Department of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bipolar Disorder / blood*,  drug therapy,  psychology*
Brain-Derived Neurotrophic Factor / blood*
Cognition / drug effects,  physiology*
Lithium / blood,  pharmacology,  therapeutic use*
Middle Aged
Neuropsychological Tests*
Reg. No./Substance:
0/Brain-Derived Neurotrophic Factor; 7439-93-2/Lithium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder.
Next Document:  Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas.